Natalia Trayanova

Dr. Natalia Trayanova is a Professor in the Department of Biomedical Engineering and the Institute for Computational Medicine at Johns Hopkins University, and holds an endowed professorship (William R. Brody Faculty Scholar). She is a Fellow of the Heart Rhythm Society, American Heart Association, and American Institute for Medical and Biological Engineering. She is the recipient of numerous awards, among which Excellence in Research and Scholarship Award (2005), Outstanding Researcher Award (2002), and Fulbright Distinguished Research Award (2002). She has published extensively and has presented at a large number of international meetings. Dr. Trayanova is Associate Editor of Frontiers in Computational Physiology and Medicine, served as Associate Editor of IEEE Transactions of Biomedical Engineering in the period 1997-2005, is on the Editorial Board of the journals Heart Rhythm and American Journal of Physiology (Heart and Circulatory System), and is an Area Editor of IEEE Reviews in Biomedical Engineering. Dr. Trayanova was the Vice-Chair in 2007 and the Chair in 2009 of the Gordon Research Conference on Cardiac Arrhythmia Mechanisms.

1books edited

2chapters authored

Latest work with IntechOpen by Natalia Trayanova

The only known effective therapy for lethal disturbances in cardiac rhythm is de?brillation, the delivery of a strong electric shock to the heart. This technique constitutes the most important means for prevention of sudden cardiac death. The efficacy of defibrillation has led to an exponential growth in the number of patients receiving implantable devices. The objective of this book is to present contemporary views on the basic mechanisms by which the heart responds to an electric shock, as well as on the challenges and implications of clinical defibrillation. Basic science chapters elucidate questions such as lead configurations and the reasons by which a defibrillation shock fails. Chapters devoted to the challenges in the clinical procedure of defibrillation address issues related to inappropriate and unnecessary shocks, complications associated with the implantation of cardioverter/defibrillator devices, and the application of the therapy in pediatric patients and young adults. The book also examines the implications of defibrillation therapy, such as patient risk stratification, cardiac rehabilitation, and remote monitoring of patient with implantable devices.

Go to the book